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Research
AbstrACt
Objectives To determine the contemporary effectiveness 
of exercise-based cardiac rehabilitation (CR) in terms of 
all-cause mortality, cardiovascular mortality and hospital 
admissions.
Data sources Studies included in or meeting the entry 
criteria for the 2016 Cochrane review of exercise-based 
CR in patients with coronary artery disease.
study eligibility criteria Randomised controlled trials 
(RCTs) of exercise-based CR versus a no-exercise control 
whose participants were recruited after the year 2000.
study appraisal and synthesis methods Two separate 
reviewers independently screened the characteristics of 
studies. One reviewer quality appraised any new studies 
and assessed their risk of bias using the Cochrane 
Collaboration’s recommended risk of bias tool. Data were 
reported as the risk difference (95% CI).
results We included 22 studies with 4834 participants 
(mean age 59.5 years, 78.4% male). We found no 
differences in outcomes between exercise-based CR and 
a no-exercise control at their longest follow-up period for: 
all-cause mortality (19 studies; n=4194; risk difference 
0.00, 95% CI −0.02 to 0.01, P=0.38) or cardiovascular 
mortality (9 studies; n=1182; risk difference −0.01, 95% CI 
−0.02 to 0.01, P=0.25). We found a small reduction in 
hospital admissions of borderline statistical significance 
(11 studies; n=1768; risk difference −0.05, 95% CI −0.10 
to −0.00, P=0.05).
Conclusions and implications of key findings Our 
analysis indicates conclusively that the current approach 
to exercise-based CR has no effect on all-cause mortality 
or cardiovascular mortality, when compared with a 
no-exercise control. There may be a small reduction in 
hospital admissions following exercise-based CR that is 
unlikely to be clinically important.
PrOsPErO registration number CRD42017073616.
bACkgrOunD 
Cardiovascular disease is the world’s biggest 
killer, accounting for 15 million deaths in 
2015.1 
Secondary prevention of coronary artery 
disease through exercise-based CR in those 
who have a diagnosis of coronary artery 
disease has the potential to reduce mortality, 
reduce hospital admissions and increase 
quality of life. Guidelines internationally 
endorse the use of exercise-based cardiac 
rehabilitation (CR) programmes.2–5
Typically, exercise-based CR aims to 
achieve 20–60 min of moderate intensity 
continuous exercise, 3–5 times a week, with 
muscular strength and endurance exercises 
prescribed in conjunction.6 Additionally, 
most programmes include supplementary 
education (coronary risk factors and cardiac 
misconceptions), advice on diet and access 
to psychological support.2 4 7 8 Typically, exer-
cise-based CR is delivered in a supervised 
centre-based setting, although home-based 
programmes are used.9
A 2016 Cochrane review (63 studies, 
n=14 486 participants) found benefits 
of exercise-based CR for patients with 
strengths and limitations of this study
 ► To our knowledge, this is the first systematic review 
of exercise-based cardiac  rehabilitation (CR) that 
has pooled data relevant to the current medical 
management of patients diagnosed with coronary 
artery disease.
 ► For analysis, we present the data as the risk 
difference (95% CI), which ensures all studies 
reporting data on the outcomes of interest were 
included.
 ► This systematic review pools data from studies that 
deliver an intervention recognised as best practice 
in exercise-based CR, where multiple approaches, 
including educational/psychosocial components, as 
well as the exercise component were used.
 ► We have not done a de novo quality assessment of 
21/22 studies included in this review and instead 
rely on a previous Cochrane assessment.
 ► We did not include health-related quality of life as 
an outcome measure as this is unsuitable for meta-
analysis.
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coronary artery disease. Both cardiovascular mortality 
(27 studies, risk ratio (RR) 0.74, 95% CI 0.64 to 0.86) 
and hospital readmissions were reduced (15 studies, 
RR 0.82, 95% CI 0.70 to 0.96), when compared with a 
no-exercise control. However, in contrast to previous 
systematic reviews and meta-analyses, there was no 
significant reduction in risk of reinfarction (36 studies, 
RR 0.90, 95% CI 0.79 to 1.04) or all-cause mortality (47 
studies, RR 0.96, 95% CI 0.88 to 1.04).10
Over recent decades, the medical management of 
coronary artery disease has been transformed. The 
introduction of primary percutaneous coronary 
intervention has reduced short-term major adverse 
cardiac events and increased long-term survival.11–14 
Simultaneously, there have also been widespread 
advances in secondary preventative medical therapy. 
This includes the introduction of aspirin and beta-
blockers in the 1980s,15 16 lipid-lowering statins and 
ACE inhibitors in the 1990s17 18 and, more recently, 
the introduction of clopidogrel, a secondary anti-
platelet, in 2007.19 20 Age-adjusted mortality has 
decreased substantially in this population.21 System-
atic reviews and meta-analyses that include data from 
older studies may not correctly assess the potential 
effect of exercise-based CR. We hypothesise that 
previous reviews have overestimated the benefit of 
exercise-based CR.
ObjECtivEs
To determine the contemporary effectiveness of exer-
cise-based CR on all-cause mortality, cardiovascular 
mortality and hospital readmissions in patients with coro-
nary artery disease.
MEthODs
We conducted and reported this meta-analysis in accor-
dance with Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses.22
search strategy
To identify relevant studies, we started with the latest 
Cochrane review of exercise-based CR in patients with 
coronary artery disease.10 Studies identified as ‘awaiting 
assessment’ or ‘on-going’ in this review were revisited 
to establish whether publication had been reached. To 
identify any new studies published since the comple-
tion of the Cochrane review, an updated search was run 
on 28 February 2017. This search used the same search 
strategies as the latest Cochrane review.10 We searched 
Cochrane Central Register of Controlled Trials (online 
supplementary appendix 1), MEDLINE (Ovid), Embase 
(Ovid) and CINAHL (EBSCO) databases. This approach 
allowed us to efficiently identify all relevant studies. 
Where appropriate, we contacted original authors for 
clarification of any new included studies.
Table 1 Risk of bias assessment for additional study
Santaularia et al29
Bias Authors’ judgement Support for judgement
Random sequence 
generation (selection 
bias) Low risk
A randomisation list in blocks of 10 was created by a computer random 
number generator. The randomisation list and the allocation of patients to 
each group were independently controlled by the Clinical Trials Unit.
Allocation concealment 
(selection bias) Low risk
A randomisation list in blocks of 10 was created by a computer random 
number generator. The randomisation list and the allocation of patients to 
each group were independently controlled by the Clinical Trials Unit.
Blinding of outcome 
assessment (detection 
bias): all outcomes Low risk
An independent committee that was blind to the patients’ treatment group 
assessed the main outcomes. This committee comprised a cardiologist, a 
rehabilitation cardiologist and a health information manager, all from different 
centres.
Incomplete outcome 
data (attrition bias): all 
outcomes Low risk There was no loss to follow-up.
Selective reporting 
(reporting bias) Low risk
All outcomes described in the methods were reported in the results. Results 
regarding quality of life are presented in supplementary data but were not 
required for the current review.
Groups balanced at 
baseline Low risk
No significant differences between groups were observed, with the exception 
of gender: 23% of the control group were women compared with 7% in the 
intervention group (P=0.049).
Intention-to-treat 
analysis conducted High risk No analysis was conducted.
Groups received same 
treatment (apart from the 
intervention) Low risk
Patients assigned to the control group received standard care given at the 
hospital. In addition to standard care, patients randomised to the intervention 
group.
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Two separate reviewers (RP and GM) independently 
screened the characteristics of studies in the latest 
Cochrane review, studies identified as ‘awaiting assess-
ment’ or ‘on-going’ and studies identified in the updated 
search. Full-text publications were retrieved to allow for 
further examination and to verify study inclusion. Any 
discrepancies were resolved by a third reviewer (MU).
Criteria for considering studies
In 1996, The Task Force on the Management of Acute 
Myocardial Infarction of the European Society of Cardi-
ology first recommended early (within 2 hours) primary 
percutaneous interventions in preference to thrombolytic 
therapy for acute myocardial infarction.23 Two years later, 
guidelines set by the Joint British recommendations on 
prevention of Coronary Heart Disease in Clinical Practice 
were published outlining the recommendations for best 
practice for secondary prevention medical therapies.24 
Although there have been some changes, notably the 
introduction of a second antiplatelet agent in the early 
2000s,19 20 the approach to secondary prevention medical 
therapies has not changed since then. Allowing time for 
implementation of these guidelines and recommenda-
tions, we identified and included studies whose partici-
pants were recruited after the year 2000 to represent a 
contemporary population engaging in exercise-based CR.
Where there was no indication of recruitment period, 
the diagnosis and the secondary preventative medical 
therapy received by participants included in the trial 
determined the inclusion or exclusion of the study in the 
analysis.
types of studies
We included randomised controlled trials of exer-
cise-based CR compared with a no-exercise control with a 
minimum follow-up period of 6 months. Data reported at 
the longest follow-up period were included in the analysis.
types of participants
We used the same entry criterion as previous Cochrane 
reviews:
 ► people who have had a myocardial infarction or who 
had undergone revascularisation (coronary artery 
bypass grafting or percutaneous coronary interven-
tion) or who have angina pectoris or coronary artery 
disease defined by angiography.
 ► on optimal secondary preventative medical therapy 
defined by the Joint British recommendations on 
prevention of Coronary Heart Disease in Clinical 
Practice.24
 ► recruited to hospital-based, community-based or 
home-based CR programmes.
types of intervention(s)
Randomised controlled trials consisted of supervised or 
non-supervised exercise-based CR. The intervention was 
exercise alone or exercise as part of a comprehensive 
CR programme (consisting of educational/psychosocial 
components). ‘No exercise control’ consisted of standard 
medical care, including optimal secondary preventative 
medical therapy, education and advice about diet and 
exercise, psychosocial support but with no formal exer-
cise intervention.
Figure 1 Summary of study selection process. RCTs, randomised controlled trials.
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types of outcome measures
We extracted data on: all-cause mortality, cardiovascular 
mortality and hospital readmissions. We did not include 
health-related quality of life as the authors of the 2016 
Cochrane review found this unsuitable for meta-analysis.
Data collection, statistical analysis and quality assessment
We pooled data using Review Manager V.5.3.25 Previous 
Cochrane reviews have presented the data as individual 
and pooled risk ratio (95% CI). Using risk ratios auto-
matically removed studies with no events in either study 
arm from the analysis. Nine studies (n=936 participants) 
reporting on all-cause mortality, cardiovascular mortality 
or hospital readmissions were excluded from one or 
more meta-analyses in the 2016 Cochrane review for this 
reason. We therefore present the data as the risk differ-
ence (95% CI), which ensures all studies reporting data 
on the outcomes of interest were included.
We applied a random-effects model to all analyses given 
the clinical heterogeneity of individual studies. Heteroge-
neity of included studies were tested statistically using the 
χ2 test of heterogeneity and I2 statistic.26
We did not repeat quality assurance checks already 
completed by the authors of the Cochrane review. For 
separate study risk of bias breakdown for these studies, we 
refer the reader to the existing characteristics of studies.10 For 
studies identified as ‘awaiting assessment’ or ‘on-going’ in 
the latest Cochrane review or in the updated search, we 
quality appraised these studies and assessed their risk of 
bias using the Cochrane Collaboration’s recommended 
risk of bias tool.27
Assessment of risk of bias in additional included study
One reviewer (RP) assessed the risk of bias in any addi-
tional included studies (table 1). Assessment of three 
further quality domains as outlined in the latest Cochrane 
review was also conducted (groups balanced at baseline, 
intention-to-treat analysis and groups received compa-
rable treatment (except exercise)). A breakdown of the 
criteria used for assessing these three domains can be 
found in the latest Cochrane review. Risk of bias assess-
ments were checked by a second reviewer (GM) and any 
discrepancies were resolved by a third reviewer (MU).
Patient involvement
No patients were involved in setting the objectives or 
outcome measures of this review, nor were they involved in 
the design or implementation. No patients were involved 
in the analysis or interpretation of the results, nor the 
writing of any drafts. There are no plans to disseminate 
the results of the review to participants included in the 
studies of the review or any relevant patient networks.
rEsults
studies retrieved
Of the 63 studies included in the Cochrane review, 
21 studies met our entry criteria. We identified two 
additional relevant papers not included in the 2016 
Cochrane review.28 29 One was excluded because data 
for our specific research question were not available in 
a useable format.28 In total, 22 studies (n=4834 partici-
pants) contributed to the analysis (figure 1). For the study 
identified from the updated search,29 there was a low risk 
of bias in all eight domains, apart from the intention-to-
treat analysis, where there was no evidence of this analysis 
being conducted (table 1).
Three studies (3/22; 14%) reported on all three 
outcomes of interest, 11 studies (11/22; 50%) reported 
on two outcomes of interest and 8 studies (8/22; 36%) 
reported on one outcome of interest.
Two studies for all-cause mortality30 31 and one study 
for cardiovascular mortality30 reported data at varying 
follow-up periods (6–12 months; >12–36 months; >3 
years). Data from these studies were taken at their longest 
follow-up period. Mean maximum follow-up period was 
24.7 months. Maximum follow-up period ranged from 24 
weeks to 10 years (table 2).
sample size, gender, age and study origin
Of our 22 studies, 10 studies were in Europe29–38 and 12 
from outside of Europe.39–50 We included a total of 4834 
participants (3788 (78.4%) males). Four studies included 
males only,30 34 45 47 and one study included women only.51 
Participants mean age was 59.5 years. The mean age for 
individual studies ranged from 47.5 to 76.9 years (table 2).
incomplete outcome data
The majority of trials (18/22; 82%) reported complete 
follow-up data, regardless of participants who were lost to 
follow-up or who dropped out. In four studies, outcome 
data were incomplete for 75 (75/4,834; 1.6%) participants 
with no description of withdrawal or dropout.41 47 48 50
Participant diagnosis of coronary artery disease and 
treatment received
The diagnosis of participants recruited to the studies was 
described in the majority of studies (21/22; 95%). Thir-
teen studies enrolled participants with mixed diagnoses, 
including angina pectoralis or coronary artery disease 
defined by angiography, myocardial infarction, percuta-
neous coronary interventions or coronary artery bypass 
grafts.32 36–42 44 46–48 50 Six studies enrolled participants 
following acute myocardial infarction only,29 31 33 34 43 49 and 
two studies enrolled participants diagnosed with angina 
pectoralis (unstable and stable angina) only.30 35 It was 
unclear from one study whether participants following 
myocardial infarction were included and instead the 
population was defined as ‘patients after coronary artery 
bypass graft surgery’45 (table 2).
Six studies recruited participants following percuta-
neous coronary intervention only30 32 33 35 41 46 and one 
study recruited participants following coronary artery 
bypass grafting only.45 Twelve studies included partici-
pants who had received thrombolysis, percutaneous coro-
nary intervention, coronary artery bypass grafting and/
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or no revascularisation procedure.31 36–40 42–44 47 48 50 Three 
studies did not provide any breakdown of coronary inter-
vention or surgical procedure received by participants 
prior to enrolment29 34 49 (table 2).
Medication
A full description and breakdown of the medication 
received by the participants, comparable with optimal 
secondary prevention medical therapy defined by the 
Joint British recommendations on prevention of Coro-
nary Heart Disease in Clinical Practice set in 1998,24 was 
provided by 13/22 studies (59%).30–33 35–40 43 49 50 Refer-
ences to coexisting medical therapies were made in 7/22 
(32%), but no breakdowns were provided.29 34 41 42 45–47 
One study referred to the prescription of antihyperten-
sive and hypolipidaemic medications without reference 
to other recommended medications.48 One study failed 
to provide any description or breakdown of coexisting 
medical therapies44 (table 2).
Clearly defined recruitment period
Seven studies (7/22; 32%) were explicit that they recruited 
participants after the year 2000.36 38 42 44–46 49 In three 
studies, participants were recruited either just before or 
during the year 2000.30 31 41 Due to participant diagnosis, 
treatment received and coexisting medical therapies, it 
was agreed by all reviewers to include these studies.
The remaining 12 studies failed to provide a recruit-
ment period. Following further examination of the full 
papers, due to adequate description of patient diagnosis, 
treatment received and coexisting medical therapies, 
it was agreed by all reviewers to include these studies 
(table 2).
Content of the interventions
The content of the interventions tested was heteroge-
neous with multiple approaches being adopted. Sixteen 
studies (16/22; 73%) compared exercise in combina-
tion with other therapies (education and psychosocial 
management), while six studies compared exercise as a 
stand-alone intervention, against a no-exercise control. 
The exercise component alone varied considerably with 
respect to setting, training modality, duration, session 
length, frequency and intensity (table 3).
Overall effects of interventions
All-cause mortality
Nineteen studies (n=4194 participants) reported all-cause 
mortality (figure 2). There was no difference between 
groups at their longest follow-up (risk difference=0.00, 
95% CI −0.02 to 0.01, P=0.38). There was no evidence 
of statistical heterogeneity across trials (P value=0.91, 
I2=0%).
Cardiovascular mortality
Nine studies (n=1182 participants) reported cardio-
vascular mortality (figure 3). There was no difference 
between groups at their longest follow-up (risk differ-
ence=−0.01, 95% CI −0.02 to 0.01, P=0.25). There was 
no evidence of statistical heterogeneity across trials (P 
value=0.44, I2=0%).
Hospital admissions
Eleven studies (n=1768 participants) reported on propor-
tion with one or more hospital admissions (figure 4). 
There was a reduction of borderline statistical signif-
icance (risk difference=−0.05, 95% CI −0.10 to −0.00, 
P=0.05). There was evidence of statistical heterogeneity 
across trials (P value=0.002, I2=64%).
DisCussiOn
The effectiveness of exercise-based CR in patients with 
coronary artery disease has been determined by Cochrane 
systematic reviews and meta-analyses, providing clini-
cians and academics with the highest level of evidence 
over the last 17 years.10 52 53 The latest Cochrane review, 
conducted in 2016, found benefits of exercise-based CR 
in terms of reduced cardiovascular mortality and hospital 
admissions, but unlike previous Cochrane reviews, found 
no effect on all-cause mortality.10 We identified that data 
from studies included in this review dated back as far as 
1975.54 By including such historical data, this Cochrane 
review may not be correctly assessing the potential effect 
of contemporary exercise-based CR.
The current review aimed to assess the effect of exer-
cise-based CR in the era of improved reperfusion strat-
egies and simultaneous advances in pharmacological 
management, by only including studies whose partic-
ipants were recruited after the year 2000. The majority 
of interventions tested in the 22 included trials (table 3) 
delivered an intervention recognised as best practice in 
exercise-based CR, where multiple approaches, including 
educational/psychosocial components, as well as the exer-
cise component were used.2 3 8 The interventions were 
tested against a no exercise control consisting of educa-
tional and psychosocial components alone (table 3).
The current analyses demonstrated no improvement 
in all-cause mortality from participation in exercise-based 
CR: the risk difference was 0.00 (95% CI −0.02 to 0.01). 
The largest trial included in our analysis, the UK-based 
Rehabilitation after myocardial infarction trial (RAMIT) 
trial, sought to show a 20% reduction in relative risk based 
on an 11% mortality, that is, a 2.2% risk difference.24 
The limits of the 95% CI for the effect size in our anal-
ysis do not include the RAMIT trial’s prespecified clin-
ically important difference. We therefore conclude that 
it is extremely unlikely that there is a worthwhile benefit 
from exercise-based CR on all-cause mortality. Further-
more, it is unlikely that future trials of similar interven-
tions and populations will change this conclusion. This is 
supported by a recent meta-analysis that included partic-
ipants with other forms of atherosclerotic cardiovascular 
disease, that is, peripheral artery disease, ischaemic cere-
brovascular accidents, diabetes and hypertension. They 
too found a zero effect on all-cause mortality (relative 
risk 1.00, 95% CI 0.88 to 1.14).55 With the mean follow-up 
 o
n
 8 M
ay 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019656 on 14 March 2018. Downloaded from 
8 Powell R, et al. BMJ Open 2018;8:e019656. doi:10.1136/bmjopen-2017-019656
Open Access 
Ta
b
le
 3
 
O
ve
rv
ie
w
 o
f e
xe
rc
is
e 
in
te
rv
en
tio
ns
R
ef
er
en
ce
, c
o
un
tr
y
E
xe
rc
is
e 
in
te
rv
en
ti
o
n
E
xe
rc
is
e
M
o
d
al
it
y
S
tu
d
y 
d
ur
at
io
n
S
es
si
o
n 
d
ur
at
io
n/
fr
eq
ue
nc
y/
in
te
ns
it
y
A
d
d
it
io
na
l
C
o
nt
ro
l
(c
o
m
p
ar
at
o
r)
A
ro
no
v 
et
 a
l,3
9  
R
us
si
a
M
od
er
at
e 
in
te
ns
ity
 
p
hy
si
ca
l t
ra
in
in
g 
(u
nk
no
w
n 
se
tt
in
g)
.
C
yc
le
 e
rg
om
et
er
.
12
 m
on
th
s
45
–6
0 
m
in
/t
hr
ee
 s
es
si
on
s 
p
er
 
w
ee
k/
50
%
–6
0%
 o
f t
he
 p
er
fo
rm
ed
 
ca
p
ac
ity
 b
y 
b
ic
yc
le
 e
rg
om
et
ry
.
N
on
e 
sp
ec
ifi
ed
.
S
ta
nd
ar
d
 m
ed
ic
al
 t
he
ra
p
y.
B
el
ar
d
in
el
li 
et
 a
l,3
2  
Ita
ly
M
od
er
at
e 
in
te
ns
ity
 
ex
er
ci
se
 (s
up
er
vi
se
d
 in
 
ho
sp
ita
l g
ym
).
C
yc
le
 e
rg
om
et
er
.
6 
m
on
th
s
53
 m
in
/t
hr
ee
 s
es
si
on
s 
p
er
 
w
ee
k/
60
%
 o
f p
ea
k 
ox
yg
en
 u
p
ta
ke
 
(V
O
2p
ea
k)
.
N
on
e 
sp
ec
ifi
ed
.
R
ec
om
m
en
d
ed
 t
o 
p
er
fo
rm
 
b
as
ic
 d
ai
ly
 m
ild
 p
hy
si
ca
l 
ac
tiv
iti
es
 b
ut
 t
o 
av
oi
d
 a
ny
 
p
hy
si
ca
l t
ra
in
in
g.
B
rif
fa
 e
t 
al
,4
0  
A
us
tr
al
ia
A
er
ob
ic
 c
irc
ui
t 
tr
ai
ni
ng
 
(s
up
er
vi
se
d
 in
 h
os
p
ita
l).
A
er
ob
ic
 c
irc
ui
t 
tr
ai
ni
ng
.
6 
w
ee
ks
60
–9
0 
m
in
/t
hr
ee
 s
es
si
on
s 
p
er
 w
ee
k/
no
t s
p
ec
ifi
ed
.
E
d
uc
at
io
n 
an
d
 
p
sy
ch
os
oc
ia
l 
co
un
se
lli
ng
.
E
d
uc
at
io
n,
 
p
ha
rm
ac
ot
he
ra
p
y 
an
d
 
lif
es
ty
le
 c
ou
ns
el
lin
g.
G
ia
lla
ur
ia
 e
t 
al
,3
3  
Ita
ly
M
od
er
at
e 
in
te
ns
ity
 
ex
er
ci
se
 (s
up
er
vi
se
d
 in
 
ce
nt
re
).
C
yc
le
 e
rg
om
et
er
.
6 
m
on
th
s
40
 m
in
/t
hr
ee
 s
es
si
on
s 
p
er
 
w
ee
k/
60
%
–7
0%
 o
f p
ea
k 
ox
yg
en
 
up
ta
ke
 (V
O
2p
ea
k)
.
N
on
e 
sp
ec
ifi
ed
.
G
en
er
ic
 in
st
ru
ct
io
ns
 o
n 
m
ai
nt
ai
ni
ng
 p
hy
si
ca
l a
ct
iv
ity
 
an
d
 a
 c
or
re
ct
 li
fe
st
yl
e.
H
am
b
re
ch
t 
et
 a
l,3
0  
G
er
m
an
y
M
od
er
at
e 
in
te
ns
ity
 
ex
er
ci
se
 (s
up
er
vi
se
d
 
in
 h
os
p
ita
l a
nd
 
un
su
p
er
vi
se
d
 a
t 
ho
m
e)
.
C
yc
le
 e
rg
om
et
er
.
12
 m
on
th
s
10
 m
in
, 4
2 
se
ss
io
ns
 p
er
 w
ee
k 
(h
os
p
ita
l),
 2
0 
m
in
, s
ev
en
 s
es
si
on
s 
p
er
 w
ee
k 
(h
om
e)
 p
lu
s 
60
 m
in
 
gr
ou
p
 t
ra
in
in
g,
 o
ne
 s
es
si
on
 p
er
 
w
ee
k/
70
%
 o
f s
ym
p
to
m
-l
im
ite
d
 m
ax
 
H
R
.
N
on
e 
sp
ec
ifi
ed
.
S
ta
nd
ar
d
 m
ed
ic
al
 t
he
ra
p
y.
H
ig
gi
ns
 e
t 
al
,4
1  
A
us
tr
al
ia
M
od
er
at
e 
in
te
ns
ity
 
w
al
ki
ng
 p
ro
gr
am
m
e 
(u
ns
up
er
vi
se
d
 a
t 
ho
m
e)
.
W
al
ki
ng
.
N
ot
 
sp
ec
ifi
ed
N
ot
 s
p
ec
ifi
ed
/n
ot
 s
p
ec
ifi
ed
/
no
t  s
p
ec
ifi
ed
.
P
sy
ch
ol
og
ic
al
 p
lu
s 
ed
uc
at
io
n.
P
sy
ch
ol
og
ic
al
 s
up
p
or
t,
 
ed
uc
at
io
n,
 c
ou
ns
el
lin
g 
an
d
 
gu
id
an
ce
.
H
ou
le
 e
t 
al
,4
2  
C
an
ad
a
P
ed
om
et
er
-b
as
ed
 
w
al
ki
ng
 p
ro
gr
am
m
e 
(u
ns
up
er
vi
se
d
 a
t 
ho
m
e)
.
W
al
ki
ng
.
12
 m
on
th
s
N
ot
 s
p
ec
ifi
ed
/n
ot
 s
p
ec
ifi
ed
/
no
t s
p
ec
ifi
ed
.
E
d
uc
at
io
n 
p
lu
s 
so
ci
oc
og
ni
tiv
e.
S
oc
io
co
gn
iti
ve
 s
up
p
or
t 
an
d
 a
d
vi
ce
 r
eg
ar
d
in
g 
p
hy
si
ca
l a
ct
iv
ity
, d
ie
t 
an
d
 
m
ed
ic
at
io
n.
K
ov
oo
r 
et
 a
l,4
3  
A
us
tr
al
ia
S
ta
nd
ar
d
 c
ar
d
ia
c 
re
ha
b
ili
ta
tio
n 
p
ro
gr
am
m
e 
(u
nk
no
w
n 
se
tt
in
g)
.
N
ot
 s
p
ec
ifi
ed
.
5  
w
ee
ks
N
ot
 s
p
ec
ifi
ed
/2
–4
 s
es
si
on
s 
p
er
 
w
ee
k/
no
t s
p
ec
ifi
ed
.
E
d
uc
at
io
n 
an
d
 
co
un
se
lli
ng
.
E
nc
ou
ra
ge
d
 t
o 
ex
er
ci
se
 a
t 
ho
m
e 
an
d
 r
et
ur
n 
to
 n
or
m
al
 
ac
tiv
iti
es
.
M
ad
d
is
on
 e
t 
al
,4
4  
N
ew
 Z
ea
la
nd
A
ut
om
at
ed
 p
ac
ka
ge
 
of
 t
ex
t 
m
es
sa
ge
s 
to
 in
cr
ea
se
 
ex
er
ci
se
 b
eh
av
io
ur
 
(u
ns
up
er
vi
se
d
 a
t 
ho
m
e)
.
M
od
er
at
e 
to
 
vi
go
ur
ou
s 
ae
ro
b
ic
 
ex
er
ci
se
, f
or
 
ex
am
p
le
, w
al
ki
ng
 
an
d
 h
ou
se
ho
ld
 
ch
or
es
.
24
 w
ee
ks
M
in
im
um
 o
f 3
0 
m
in
/a
t l
ea
st
 fi
ve
 
se
ss
io
ns
 p
er
 w
ee
k/
no
t s
p
ec
ifi
ed
.
O
p
tio
na
l a
cc
es
s 
to
 
ot
he
r 
C
R
 s
er
vi
ce
 o
r 
su
p
p
or
t.
B
eh
av
io
ur
 c
ha
ng
e 
th
er
ap
y ,
 
en
co
ur
ag
em
en
t 
to
 b
e 
p
hy
si
ca
lly
 a
ct
iv
e 
an
d
 a
d
vi
ce
 
to
 a
tt
en
d
 a
 c
ar
d
ia
c 
cl
ub
.
C
on
tin
ue
d
 o
n
 8 M
ay 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019656 on 14 March 2018. Downloaded from 
9Powell R, et al. BMJ Open 2018;8:e019656. doi:10.1136/bmjopen-2017-019656
Open Access
R
ef
er
en
ce
, c
o
un
tr
y
E
xe
rc
is
e 
in
te
rv
en
ti
o
n
E
xe
rc
is
e
M
o
d
al
it
y
S
tu
d
y 
d
ur
at
io
n
S
es
si
o
n 
d
ur
at
io
n/
fr
eq
ue
nc
y/
in
te
ns
it
y
A
d
d
it
io
na
l
C
o
nt
ro
l
(c
o
m
p
ar
at
o
r)
M
ar
ot
o 
M
on
te
ro
 e
t 
al
,3
4  
S
p
ai
n
In
d
iv
id
ua
lis
ed
 p
hy
si
ca
l 
tr
ai
ni
ng
 (s
up
er
vi
se
d
 in
 
ho
sp
ita
l g
ym
).
P
hy
si
ot
he
ra
p
y 
an
d
 
ae
ro
b
ic
 t
ra
in
in
g 
on
 m
at
s 
or
 a
 c
yc
le
 
er
go
m
et
er
.
3 
m
on
th
s
60
 m
in
/t
hr
ee
 s
es
si
on
s 
p
er
 
w
ee
k/
75
%
–8
5%
 m
ax
 H
R
.
P
sy
ch
ol
og
ic
al
 s
up
p
or
t,
 
ed
uc
at
io
n 
p
lu
s 
re
tu
rn
 t
o 
w
or
k 
co
un
se
lli
ng
.
P
sy
ch
ol
og
ic
al
 s
up
p
or
t,
 
ed
uc
at
io
n 
p
lu
s 
re
tu
rn
 t
o 
w
or
k 
co
un
se
lli
ng
.
M
un
k 
et
 a
l,3
5  
N
or
w
ay
M
od
er
at
e/
hi
gh
 in
te
ns
ity
 
in
te
rv
al
 t
ra
in
in
g 
(s
up
er
vi
se
d
 in
 c
en
tr
e)
.
C
yc
le
 e
rg
om
et
er
 o
r 
ru
nn
in
g.
6 
m
on
th
s
60
 m
in
/t
hr
ee
 s
es
si
on
s 
p
er
 
w
ee
k/
60
%
–7
0%
 a
nd
 8
0%
–
90
%
 m
ax
 H
R
.
S
p
in
e 
an
d
 a
b
d
om
in
al
 
re
si
st
an
ce
 t
ra
in
in
g.
U
su
al
 c
ar
e,
 in
cl
ud
in
g 
d
ru
g 
th
er
ap
y.
M
ut
w
al
li 
et
 a
l,4
5  
S
au
d
i A
ra
b
ia
M
od
er
at
e 
in
te
ns
ity
 
w
al
ki
ng
 p
ro
gr
am
m
e 
(u
ns
up
er
vi
se
d
 a
t 
ho
m
e)
.
W
al
ki
ng
.
6 
m
on
th
s
30
 m
in
/s
ev
en
 s
es
si
on
s 
p
er
 w
ee
k/
no
t s
p
ec
ifi
ed
.
E
d
uc
at
io
n.
E
d
uc
at
io
n,
 s
ta
nd
ar
d
 
ho
sp
ita
l c
ar
e
O
er
ki
ld
 e
t 
al
,3
6  
D
en
m
ar
k
M
od
er
at
e 
in
te
ns
ity
 
ex
er
ci
se
 (u
ns
up
er
vi
se
d
 
at
 h
om
e)
.
In
d
iv
id
ua
lis
ed
.
12
 m
on
th
s
30
 m
in
/s
ix
 s
es
si
on
s 
p
er
 w
ee
k/
11
–
13
 o
n 
th
e 
B
or
g 
S
ca
le
.
R
is
k 
fa
ct
or
 
m
an
ag
em
en
t.
U
su
al
 c
ar
e,
 n
o 
ex
er
ci
se
 
ed
uc
at
io
n 
or
 d
ie
ta
ry
 
co
un
se
lli
ng
.
R
ei
d
 e
t 
al
,4
6  
C
an
ad
a
In
te
rn
et
-b
as
ed
 
p
hy
si
ca
l a
ct
iv
ity
 p
la
n 
an
d
 m
ot
iv
at
io
na
l t
oo
l 
to
 in
cr
ea
se
 p
hy
si
ca
l 
ac
tiv
ity
 (u
ns
up
er
vi
se
d
 
at
 h
om
e)
.
N
ot
 s
p
ec
ifi
ed
.
20
 w
ee
ks
N
ot
 s
p
ec
ifi
ed
/n
ot
 s
p
ec
ifi
ed
/
no
t s
p
ec
ifi
ed
.
N
on
e 
sp
ec
ifi
ed
.
O
nl
in
e 
ed
uc
at
io
n,
 p
hy
si
ca
l 
ac
tiv
ity
 g
ui
d
an
ce
 a
nd
 a
n 
ed
uc
at
io
n 
b
oo
kl
et
.
S
an
ta
ul
ar
ia
 e
t 
al
,2
9  
S
p
ai
n
O
ut
p
at
ie
nt
 e
xe
rc
is
e 
tr
ai
ni
ng
 p
ro
gr
am
m
e 
(s
up
er
vi
se
d
 in
 h
os
p
ita
l).
C
yc
le
 e
rg
om
et
er
.
10
 w
ee
ks
60
 m
in
/t
hr
ee
 s
es
si
on
s 
p
er
 
w
ee
k/
75
%
–9
0%
 m
ax
 H
R
 (R
P
E
 
11
–1
5 
on
 B
or
g 
S
ca
le
)
R
es
is
ta
nc
e 
tr
ai
ni
ng
, 
ed
uc
at
io
n 
an
d
 r
is
k 
fa
ct
or
 m
an
ag
em
en
t.
S
ta
nd
ar
d
 c
ar
e,
 r
is
k 
fa
ct
or
 
m
an
ag
em
en
t,
 g
ui
d
an
ce
 
on
 p
hy
si
ca
l a
ct
iv
ity
 a
nd
 
ad
he
re
nc
e 
to
 m
ed
ic
at
io
n.
S
ek
i e
t 
al
,4
7  
Ja
p
an
M
od
er
at
e 
in
te
ns
ity
 
ae
ro
b
ic
 e
xe
rc
is
e 
(s
up
er
vi
se
d
 in
 c
en
tr
e 
an
d
 u
ns
up
er
vi
se
d
 a
t 
ho
m
e)
.
W
al
ki
ng
, c
yc
le
 
er
go
m
et
er
 a
nd
 
jo
gg
in
g.
6  
m
on
th
s
50
–1
10
 m
in
, o
ne
 s
es
si
on
 p
er
 w
ee
k 
(c
en
tr
e)
, ≥
30
 m
in
, t
w
o 
se
ss
io
ns
 p
er
 
w
ee
k 
(h
om
e)
/1
2–
13
 o
n 
th
e 
st
an
d
ar
d
 
B
or
g 
S
ca
le
.
E
d
uc
at
io
n.
E
d
uc
at
io
n 
an
d
 o
ut
p
at
ie
nt
 
fo
llo
w
-u
p
 w
ith
 p
hy
si
ci
an
.
To
ob
er
t 
et
 a
l,4
8  
U
S
A
W
al
ki
ng
 o
r 
ae
ro
b
ic
s 
(s
up
er
vi
se
d
 in
 c
en
tr
e 
an
d
 u
ns
up
er
vi
se
d
 a
t 
ho
m
e)
.
W
al
ki
ng
 o
r 
ae
ro
b
ic
s.
24
 m
on
th
s
60
 m
in
, s
ev
en
 s
es
si
on
s 
p
er
 w
ee
k 
(c
en
tr
e)
, 6
0 
m
in
, t
hr
ee
 s
es
si
on
s 
p
er
 
w
ee
k 
(h
om
e)
/in
d
iv
id
ua
lly
 p
re
sc
rib
ed
.
E
d
uc
at
io
n 
an
d
 
p
sy
ch
ol
og
ic
al
 s
up
p
or
t.
C
oo
ki
ng
 c
la
ss
es
, s
tr
es
s 
m
an
ag
em
en
t 
an
d
 
ed
uc
at
io
n.
Ve
st
fo
ld
 H
ea
rt
ca
re
 
S
tu
d
y 
G
ro
up
,3
7  
N
or
w
ay
D
yn
am
ic
 e
nd
ur
an
ce
 
p
hy
si
ca
l a
ct
iv
ity
 
(s
up
er
vi
se
d
, g
ro
up
 
se
ss
io
ns
 in
 c
en
tr
e)
.
D
yn
am
ic
 e
nd
ur
an
ce
 
tr
ai
ni
ng
.
15
 w
ee
ks
55
 m
in
/t
w
o 
se
ss
io
ns
 p
er
 w
ee
k/
R
P
E
 
11
–1
3 
on
 t
he
 B
or
g 
S
ca
le
, i
nc
re
as
ed
 
to
 1
3–
15
 a
ft
er
 6
 w
ee
ks
.
E
d
uc
at
io
n 
an
d
 
p
sy
ch
ol
og
ic
al
 s
up
p
or
t.
E
d
uc
at
io
n 
an
d
 
p
sy
ch
ol
og
ic
al
 s
up
p
or
t.
Ta
b
le
 3
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 8 M
ay 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019656 on 14 March 2018. Downloaded from 
10 Powell R, et al. BMJ Open 2018;8:e019656. doi:10.1136/bmjopen-2017-019656
Open Access 
period for all studies included in our review being 24.7 
months, it may be that any benefits on mortality will 
accrue over a longer follow-up. However, the absence 
of any kind of signal in this review means a substantial 
longer term benefit is unlikely.
The current analyses do not quite exclude a worthwhile 
benefit of exercise-based CR on hospital admissions. 
While a risk difference of −0.05 (95% CI −0.10 to −0.00) 
is of borderline statistical significance, it is probably clini-
cally unimportant in the context of no change in all-cause 
mortality.
From the studies included in this review, we do not 
know if there is a worthwhile benefit on quality of life, as 
a meta-analysis was not conducted. However, the authors 
of the 2016 Cochrane review reported that in 4 of the 
22 studies included in this review, there was a signifi-
cantly higher quality of life in at least half or more of the 
subscales.32 45 46 49
Based on the present data, we are also unable to 
comment on whether exercise-based CR might be cost-ef-
fective. Five of the studies in this review included a with-
in-trial health economic evaluation.30 40 43 44 50 Of these 
five papers, three studies showed no difference in health-
care costs between groups,40 43 50 one found healthcare 
costs to be lower for exercise-based CR30 and one failed to 
report a P value for cost difference.44 While a decrease, of 
borderline statistical significance, in hospital admissions 
may improve quality of life for patients, it is unclear if this 
confers any economic benefit, in the absence of robust 
cost-effectiveness analyses.
It may be that exercise-based CR has an effect on other 
outcomes, not specifically addressed in this review, such 
as cardiorespiratory fitness, lifestyle risk factor manage-
ment, adherence to medication, diet, smoking cessation, 
psychosocial health and return to work.7 8 56 57 If the focus 
of future research is on measuring and improving these 
outcomes, attention will be needed to develop the best 
multicomponent intervention.
strengths and limitations
To our knowledge, this is the first systematic review 
of exercise-based CR that has pooled data relevant to 
contemporary medical management of patients diag-
nosed with coronary artery disease. Although we have 
not done a de novo quality assessment of 21/22 studies 
included in this review and instead are relying on a 
previous Cochrane assessment, it is unlikely that we 
would have drawn different conclusions from such an 
assessment.10
The current review does not provide information on 
participant baseline characteristics. In the majority of 
studies (20/22; 91%), however, baseline characteristics 
were comparable between the intervention and control 
groups.10 29
While there was no evidence of statistical hetero-
geneity across trials for all outcome measures (P 
value <0.01, I2 >30%), except for hospital admissions, 
there was substantial context and interventional R
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heterogeneity. The studies came from a wide range 
of clinical environments and countries, and the inter-
ventions delivered ranged greatly in quality. When 
compared with both the BACPR ‘minimum standards 
and core components’8 and Association of Chartered 
Physiotherapists in Cardiac Rehabilitation (ACPICR) 
guidelines,6 there was considerable variation in the 
exercise interventions delivered (table 3). Critics have 
questioned the exercise component reported in the 
largest included study—the RAMIT trial (n=1813).31 
They argued that underdosage of exercise intensity 
and duration may have led to the inconclusive result.58 
Several other studies included in this review also fail 
to report on the intensity, modality and/or duration 
of the exercise intervention. Exercise and physical 
activity has a ‘dose–response’ relationship with cardio-
vascular disease risk.59 Moreover, a higher exercise 
capacity (VO2 peak) is associated with an improvement 
in mortality risk.60 61 If patients engaging in exer-
cise-based CR do not achieve the correct dose of exer-
cise, a physiological benefit is unlikely. It is a legitimate 
concern that participants in many included trials may 
not have received an adequate dose of exercise. In the 
era of contemporary medical management, higher 
intensity exercise protocols might be appropriate and 
effective.62
One major concern is the reporting of adherence 
to, and fidelity of, exercise interventions.10 While the 
majority of studies included in this review report the 
intended prescription exercise dose29 30 32–37 39 40 47 50 
(table 3), it is not possible to determine adherence and 
fidelity. Without basic reporting of these parameters, 
the actual exercise dose received cannot be quantified. 
This may have a significant bearing on intervention 
efficacy and the results of this meta-analysis. Moving 
forward, the introduction of checklists and reporting 
Figure 2 All-cause mortality for studies at their longest follow-up period. Filled squares represent the risk difference for 
individual studies at the longest reported follow-up. The boxes are proportional to the weight of each study, and the lines 
represent their 95% CI. The filled diamond represents the pooled risk difference. Weights are from random effects analysis. CR, 
cardiac rehabilitation.
Figure 3 Cardiovascular mortality for studies at their longest follow-up period. Filled squares represent the risk difference 
for individual studies at the longest reported follow-up. The boxes are proportional to the weight of each study and the lines 
represent their 95% CI. The filled diamond represents the pooled risk difference. Weights are from random effects analysis. CR, 
cardiac rehabilitation.
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standards of interventional studies should improve 
reporting quality and trial interpretation.63
COnClusiOn
Based on the outcomes of all-cause mortality and 
cardiovascular mortality, our analysis indicates conclu-
sively that the current approach to exercise-based 
CR has no effect when compared with a no-exercise 
control. There may be a small reduction in hospital 
admissions following exercise-based CR that is unlikely 
to be clinically important.
The continued delivery of exercise-based CR needs 
to be supported by new research to show its impact on 
health-related quality of life and whether it is a cost-effective 
intervention.
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